CORPORATE HIGHLIGHTS

• Privately-held clinical stage Montreal-based biotechnology company
• Engaged in the discovery and development of therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets
• Currently, having one program with Phase II data